Article
Myeloperoxidase -463 G/A polymorphism is associated with lung cancer risk: A meta-analysis with 7420 cases and 9132 controls.
Journal of cancer research and therapeutics - 1 Jun 2018
Zou Shengqiang, Pan Xin, Hua Changsong, Wu Min, He Bin, Chen Zhigang
Abstract excerpt
AIMS: Several studies evaluated the association between myeloperoxidase (MPO) -463 G/A polymorphism and the risk of lung cancer. However, the results were not stable. MATERIALS AND METHODS: Online electronic databases (PubMed, EMBASE, and Wanfang database) were searched. The strength of association between the MPO -463 G/A polymorphism and lung cancer risk was assessed by calculating odds ratios (OR) with 95%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
